Professor Harry Iland will be presenting at the 24th Congress of the European Hematology Association (EHA) the interim results of an exciting Australian clinical trial for people suffering with a form of Acute Myeloid Leukaemia.
The Australasian Leukaemia and Lymphoma Group (ALLG) are pleased to announce the launch of the APML5 interim clinical trial results at the 24th Congre ...
Today, the Australasian Leukaemia and Lymphoma Group (ALLG) and the Snowdome Foundation are pleased to announce an exciting new partnership in the fight against blood cancer.
The partnership will see the implementation of an important international clinical trial designed to measure the benefits of different treatment optio ...
Today, the Australasian Leukaemia and Lymphoma Group (ALLG) is excited to announce the launch of a new clinical trial that aims to improve the treatment of Australian adolescents and young adults with Acute Lymphoblastic Leukaemia (ALL).
With the support of the Medical Research Future Fund (MRFF) via CanTeen, the ALLG’s new clinical trial (ALL9) aims to improve outcomes in Adolescent a ...
Satisfied Users & 
Approved Press Releases
